在广泛的测试中对通用突变p53-rescue化合物的表征
Shujun Xiao1, Fangfang Shi2, Huaxin Song2
1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Cancer cell
|February 25, 2024
概括
研究人员评估了突变的p53-rescue化合物,发现只有三氧化 (ATO) 和其模拟PAT有效. 大多数化合物在广泛的测试中未能显示可靠的救援,突出了针对突变p53.3的挑战.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 突变的p53蛋白经常在瘤中发现,并导致癌症的发展.
- 许多化合物已经开发出,旨在拯救突变的p53功能.
- 评估这些化合物的疗效对于治疗进步至关重要.
相关概念视频
01:16In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...